222 related articles for article (PubMed ID: 22160250)
1. Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.
Ho TJ; Huang CC; Huang CY; Lin WT
Eur J Appl Physiol; 2012 Aug; 112(8):2943-55. PubMed ID: 22160250
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis.
Wang ZH; Zhu D; Xie S; Deng Y; Pan Y; Ren J; Liu HG
J Cardiovasc Pharmacol; 2017 Aug; 70(2):102-109. PubMed ID: 28437280
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
[TBL] [Abstract][Full Text] [Related]
5. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
7. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a direct cellular protective effect of Rho-kinase inhibitors on endothelin-induced cardiac myocyte hypertrophy.
Satoh S; Kawasaki K; Ikegaki I; Asano T; Shimokawa H
Biochem Biophys Res Commun; 2012 Jul; 424(2):338-40. PubMed ID: 22771803
[TBL] [Abstract][Full Text] [Related]
9. [The expression of Rho/Rho kinase of cardiac muscle in heart failure rats caused by pressure overload and the intervention of fasudil].
Zhang M; Qu C; Zeng DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):73-6. PubMed ID: 15924788
[TBL] [Abstract][Full Text] [Related]
10. Rho Kinase Inhibition by Fasudil Attenuates Adriamycin-Induced Chronic Heart Injury.
Yan Y; Xiang C; Yang Z; Miao D; Zhang D
Cardiovasc Toxicol; 2020 Aug; 20(4):351-360. PubMed ID: 31894538
[TBL] [Abstract][Full Text] [Related]
11. [Effects of rho-kinase inhibitor on cardiac hypertrophy of left ventricle in spontaneously hypertensive rats].
Zhang ZJ; Fan YF; Zhang ZY; Xie PY; Fang HC; Su YS
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3438-41. PubMed ID: 23327708
[TBL] [Abstract][Full Text] [Related]
12. Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase.
Ying Z; Yue P; Xu X; Zhong M; Sun Q; Mikolaj M; Wang A; Brook RD; Chen LC; Rajagopalan S
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1540-50. PubMed ID: 19286943
[TBL] [Abstract][Full Text] [Related]
13. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
[TBL] [Abstract][Full Text] [Related]
14. Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling.
Ocaranza MP; Fierro C; Jalil JE; Moya J; Gonzalez L; Molina C; Mancilla C
Clin Sci (Lond); 2018 Aug; 132(16):1837-1853. PubMed ID: 30065083
[TBL] [Abstract][Full Text] [Related]
15. Rho-kinase inhibition reverses impaired Ca
Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
17. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
[TBL] [Abstract][Full Text] [Related]
18. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
Xie Y; Song T; Huo M; Zhang Y; Zhang YY; Ma ZH; Wang N; Zhang JP; Chu L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
[TBL] [Abstract][Full Text] [Related]
19. RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism.
Na W; Peng G; Jianping Z; Yanzhong C; Shengjiang G; Li C
Toxicol Ind Health; 2012 Oct; 28(9):831-9. PubMed ID: 22072613
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of a combination of Rho-kinase inhibitor and p38 MAPK inhibitor on cardiovascular remodeling and oxidative stress in Dahl rats.
Takeshima H; Kobayashi N; Koguchi W; Ishikawa M; Sugiyama F; Ishimitsu T
J Atheroscler Thromb; 2012; 19(4):326-36. PubMed ID: 22166971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]